Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Norway

European Innovation Council · Running

Picterus Jaundice mHealth platform Bringing newborn care home: An integral mHealth solution for neonatal jaundice management.

Coordinator
Picterus AS, Norway
Runs
1 September 2023 to 31 August 2025
Status
Running
EU funding
€2.5m
Total cost
€3.9m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190162545

What the project is doing

In the project's own words, from its summary on CORDIS.

Neonatal jaundice (NNJ) affects 60%-80% of newborns worldwide (84-112 million/year). Ten percent will develop severe jaundice (SNJ), which can cause permanent brain damage or even death (114,000 newborns die/year, 75,000 suffer severe long-term neurological impairments). A fast, point-of-care, affordable method for NNJ screening and monitoring in the first 2 weeks of life is crucial, but current methods are insufficient (e.g. visual assessment, transcutaneous device, blood test).

Health systems face increasing pressure on their resources. It is imperative to develop more sustainable models of care and empower patients and their families. Picterus is developing the first digital platform to enable NNJ screening by parents and caregivers at home, and a timely referral to healthcare services. Our recommendation tool will allow families to monitor NNJ at home with their smartphones, and healthcare workers to efficiently manage a greater number of families by avoiding unnecessary visits.

Topics

Who is involved

OrganisationCityCountryRole
Picterus ASTrondheimNorwayCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI